A7GG92 AF NFT

Probable dual-specificity RNA methyltransferase RlmN

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiedcsm6ttga6lcvbvwozovkn7an3ss5vpcy7pzyidsn6jkkl3dzrm/metadata.json
IPFS of structure file: 
bafybeiew7ujs47antmr6eaogspexji637lrvvbnmxqphsitbugrdzojofu/AF-A7GG92-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5e58272ea25a05e06901A2eAe9f63939b344e0c6
First NFT owner address (bech32): 
genesis1tevzwt4ztgz7q6gp5t4wna3e8xe5fcxxnzlgjh
Current NFT ID #378201 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
378201
Accession (UniProt):
A7GG92
Name::
Probable dual-specificity RNA methyltransferase RlmN
Experimental Method:
Predicted structure
Sequence source:
Clostridium botulinum (strain Langeland / NCTC 10281 / Type F)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT A7GG92 research and analysis (ICN3D with VR)

FASTA sequences

>sp|A7GG92|RLMN_CLOBL Probable dual-specificity RNA methyltransferase RlmN OS=Clostridium botulinum (strain Langeland / NCTC 10281 / Type F) OX=441772 GN=rlmN PE=3 SV=1 MENILDFTLEELKEWLISKEEKAFRAKQVFDWIYNKLIFDFNNMKNIPYKTKNLLSDNFYVGVPKVVKKLMSQDKNTYKFLFEYKDGNIIESVVMKYKHGNSICVSTQVGCRMGCKFCASTLDGVIRNLTSGEILSQIMAAQKEIGERISNVVLMGSGEPLDNFQNVTKFLDLVTSDTTLNIGQRHITLSTCGIVPKIKELADKNYNITLAISLHSPEDLLRKEMMPIANKYSIKELMEACDYYINKTNRRITFEYALVKGKNDSIKEAKKLSTVLKGKLCHVNLIPVNEIKENSYEKSTLKNIESFGNILKENGIETTIRREMGADINAACGQLRRSYVSK